세계 컴퓨터 단층촬영(CT) 기기 시장 규모는 2023년 61억 3,000만 달러, 2030년까지 88억 7,000만 달러에 달할 것으로 예상되며, 2024-2030년 예측 기간 동안 연평균 6.36% 성장할 것으로 예상됩니다. 시장은 심혈관, 종양 및 기타 질병과 같은 심각한 만성 질환의 이환율 증가, 급속한 기술 개발 활동, 조기 발견에 대한 인식 증가, 노인 인구 증가 등으로 인해 2024-2030년 예측 기간 동안 플러스 성장을 보일 것으로 예상됩니다.
CT 기기 시장 역학
CT 기기 시장은 다양한 요인으로 인해 제품 수요가 증가하고 있습니다. 주요 요인으로는 뼈, 혈관, 연부조직을 동시에 촬영할 수 있는 CT의 장점, 관상동맥 질환, 혈전과 같은 심혈관 질환과 같은 만성 질환의 진단에 널리 사용되는 CT, 알츠하이머병 및 기타 인지 기능 저하의 원인으로 평가되는 인지 기능 장애를 가진 성인 환자의 뇌 기능 이상을 감지하는 데에도 CT 영상이 사용됩니다. 인지 기능 장애가 있는 성인 환자의 뇌 기능 이상을 감지하는 데도 사용됩니다.
만성 질환뿐만 아니라 CT 스캔은 종양의 존재 여부, 위치, 크기 등을 확인할 수 있으며, CT 스캔은 종양에 영양을 공급하는 혈액 동맥을 밝힐 수도 있습니다. 이 검사는 의사가 암이 폐나 간과 같은 다른 신체 부위로 퍼졌는지 여부를 확인하기 위해 사용하기도 합니다. 또한 CT 스캔은 의사가 바늘을 꽂아 조직을 채취할 때에도 자주 사용됩니다. CT 스캔은 열을 이용하여 악성 종양을 제거하는 RF 절제술(RFA)과 같은 암 치료를 위해 종양에 바늘을 유도하는 데에도 사용될 수 있으며, 따라서 암의 유병률 증가는 세계 CT 기기 시장의 또 다른 주요 성장 요인으로 작용하고 있습니다. 세계보건기구(WHO) 국제암연구소에 따르면 2020년 전 세계적으로 약 120만 명의 젊은 성인(20-39세)이 암 진단을 받았고, 36만 명이 암으로 사망했습니다.
따라서 생존율은 질병의 치료 경로에 따라 달라지므로 조기 발견은 치료에 필수적입니다. 효율적인 CT 스캔을 통해 질병을 더 잘 진단할 수 있습니다. 따라서 암 유병률의 증가는 CT 장치에 대한 수요 증가로 이어져 예측 기간 동안 전체 CT 장치 시장의 성장에 기여할 것으로 예상됩니다.
CT 기기 시장의 또 다른 주요 성장 요인은 전 세계적으로 노인 인구가 증가하고 있다는 점입니다. 세계보건기구(WHO) 자료에 따르면 2020년 전 세계적으로 약 10억 명이 60세 이상 인구가 될 것으로 예상됩니다. 또한 2050년까지 60세 이상 노년 인구는 두 배로 증가하여 약 21억 명에 달할 것으로 예상되며, 80세 이상 노년 인구는 2020-2050년 사이 3배 증가하여 4억 2,600만 명에 달할 것으로 추정됩니다. 노화는 신체 내부 및 뼈 손상 검사, 척추 문제 및 골격 손상 진단, 골다공증 감지 등 다양한 질병의 발병과 관련된 주요 위험 요소 중 하나로 간주되기 때문에 노령 인구의 증가는 전 세계적으로 만성 질환 환자 수의 증가로 이어질 것으로 예상되며, 이는 예측 기간 동안 CT 기기의 수요 증가로 이어져 CT 기기 시장의 성장을 촉진할 것으로 예상됩니다.
위 요인 외에도 64 슬라이스 CT 시스템 도입과 같은 신기술 개발 등 CT 장치 분야의 기술 개발도 시장에 기여하고 있으며, 주요 제조업체들은 화질 향상과 스캔 시간 단축을 위한 고슬라이스 CT 시스템 개발에 적극 나서고 있습니다. 또한, 소형화 및 휴대가 가능한 장비 구축을 위한 이미징 기술 강화도 CT 장비의 긍정적인 성장을 가져오는 요인입니다. 이러한 장점들이 세계 CT 기기 시장의 성장을 견인하고 있습니다.
그러나 높은 비용과 스캔 중 조사되는 이온화 방사선의 양이 CT 기기 시장의 성장을 저해하는 요인으로 작용하고 있습니다.
COVID-19의 발생은 CT 스캔을 임상 검사와 함께 COVID-19의 진단 도구 중 하나로 CT 스캔의 사용을 광범위하게 증가시켰습니다. 배경 흉부 CT는 COVID-19 진단에 사용되어 역전사 중합효소 연쇄 반응(RT-PCR) 검사를 보완하는 데 중요한 역할을 했습니다. 그 결과, 팬데믹 기간 동안 CT 장비에 대한 수요가 증가했습니다. 또한, 팬데믹 이후 경제 상황이 정상화되고 봉쇄 규제가 완화되고 경제가 회복되는 과정에서 정상적인 의료 서비스가 재개됨에 따라 CT 기기 시장에서 이러한 제품에 대한 수요가 증가했습니다.
이 보고서는 세계 CT 기기 시장에 대해 조사 분석했으며, 시장 규모와 예측, 촉진요인 및 과제, 기업 및 제품 프로파일 등을 조사 분석하여 전해드립니다.
Computed Tomography (CT) Devices Market By Type (Stationary CT Scanners, Portable CT Scanners), By Modality (O-Arm, C-Arm), By Technology (Low End, Mid-End, High End), By Application (Oncology, Cardiology, Neurology, Others), By End-User (Hospitals, Diagnostic Imaging Centres, Others), by geography is expected to grow at a steady CAGR forecast till 2030 owing to rising incidence various chronic diseases and rapid technological developmental activities
Global Computed Tomography (CT) Devices Market was valued at USD 6.13 billion in 2023, growing at a CAGR of 6.36% during the forecast period from 2024 to 2030 to reach USD 8.87 billion by 2030. The Computed Tomography (CT) Devices market is witnessing positive growth owing to the rising incidence of severe chronic diseases such as cardiovascular, oncology, and others, further rapid technological developmental activities, growing awareness for early detection, and increasing incidences of the aging population, thereby contributing to the growth of the Computed Tomography (CT) Devices market during the forecast period from 2024-2030.
Computed Tomography Devices Market Dynamics:
The Computed Tomography (CT) Devices market is witnessing a growth in product demand owing to various reasons. The key factor includes the advantage offered by Computed Tomography for its ability to image bone, blood vessels, and soft tissue at the same time, which helps in the detection of various disorders in the patient. CT is widely used to diagnose chronic diseases like cardiovascular diseases such as coronary artery disease, blood clots among others. CT imaging is also used to detect abnormal brain function in adult patients with cognitive impairment who are being evaluated for Alzheimer's disease and other causes of cognitive decline.
In addition to chronic diseases, a CT scan can reveal whether or not a patient has a tumor, as well as where it is located and how large it is. CT scans can also reveal the blood arteries that provide the tumor with nutrients. These scans might be used by doctors to check if cancer has spread to other regions of the body, such as the lungs or liver. Moreover, CT scans are frequently used by doctors to guide a needle through a tiny bit of tissue. This is called a CT-guided biopsy. CT scans can also be used to guide needles into tumors for cancer therapies like radiofrequency ablation (RFA), which utilizes heat to eliminate malignancies, therefore the rising prevalence of cancers is another important factor responsible for the growth of the Global Computed Tomography Devices market. As per International Agency for Research on Cancer, WHO 2022, around 1.2 million young adults (aged 20-39) were diagnosed with cancer globally in 2020, and 360,000 died from the disease.
Hence, early detection is essential for a cure because survival is dependent on the treatment pathway for the disease. With efficient CT scans, the diagnosis of diseases becomes better. Therefore, the increasing prevalence of cancer is projected to lead to the growing demand for Computed Tomography Devices, thereby contributing to the growth of the overall Computed Tomography Devices market during the forecast period.
Another key factor responsible for the growth of the Computed Tomography Devices market is the increasing geriatric population base across the globe. According to the data provided by the World Health Organization, in 2020, about one billion people across the world were over the age of 60. The source further stated that by 2050, the elderly population in the 60 and above age group is expected to double in number representing about 2.1 billion people, and people in the age group of 80 and above are estimated to triple between 2020 and 2050 to reach 426 million. Age is considered as one of the key risk factors associated with the development of various disorders such as examining internal and bone injuries, diagnosing spinal problems and skeletal injuries, detecting osteoporosis, therefore, the rising elderly population is expected to lead to a rise in the patient population of chronic diseases across the world, which in turn would lead to an increase in demand for Computed Tomography Devices in the forecast period, which will drive the Computed Tomography Devices market growth.
Along with the factors mentioned above, technological advancements in the field of Computed Tomography Devices such as the development of new techniques like the introduction of 64 slices CT systems is also contributing to the market, key manufacturers are actively involved in developing higher slice CT systems to augment image quality, lesser scanning time. Moreover, enhancement in imaging techniques to build smaller and portable equipment is another factor that has led to the positive growth of Computed Tomography Devices. These benefits thereby by boosting the growth of the Global Computed Tomography Devices market.
However, high costs and doses of ionizing radiation delivered during scanning may be certain limiting factors of the Computed Tomography Devices market growth.
COVID-19 outbreak has extensively instigated increased use of CT scans, as it is one of the diagnostic tools for COVID along with laboratory tests. Background Chest CT was used in the diagnosis of coronavirus disease and it was an important complement to reverse-transcription polymerase chain reaction (RT-PCR) tests. This resulted in the increased demand for Computed Tomography Devices during the pandemic. Moreover, the process of economic recovery with the easing of lockdown restrictions and the return of normalcy in the economic landscape post pandemically made the resumption of regular healthcare services, which kept the demand for these products on course in the Computed Tomography Devices market.
Computed Tomography Devices Market Segment Analysis:
Computed Tomography Devices Market By Type (Stationary CT Scanners, Portable CT Scanners), By Modality (O-arm, C-arm), By Technology (Low end, Mid end, High end), By Application (Oncology, Cardiology, Neurology, Others), By End-User (Hospitals, Diagnostic Imaging Centres, Others), and By Geography (North America, Europe, Asia-Pacific, and Rest of the World)
In the Technology segment of the Computed Tomography Devices market, the High-end scanners are estimated to hold a higher share in the Computed Tomography Devices market during the forecast period. This can be attributed to the specific features associated with these devices.
The dominance of this segment is owing to the strong installation base globally of these systems. Several market players have a strong portfolio of High-end scanners and are now actively being involved to significantly develop 256 slice scanner systems. These systems help in scanning an organ, including the brain, heart, entire joints, lungs, and liver. A High-end machine is faster than a low or mid-end system. Another added advantage associated with High end is that they have superior imaging qualities, higher spatial resolution.
Therefore, considering the advantages associated with High-end systems, this product category is expected to generate significant revenue share eventually contributing to the overall growth of the global Computed Tomography Devices market during the forecast period.
North America is expected to dominate the overall Computed Tomography Devices Market:
Among all the regions, North America is expected to account for the largest share in the Global Computed Tomography Devices market. Factors such as the rising incidence of cancer cases, increase in the utilization of CT, technical improvements, strong financial incentives, and increased product launches are expected to aid in the growth of the North America Computed Tomography Devices Market.
The cases of cancer are rising constantly in North America. These cases promote the need for use of CT in disease diagnosis. For instance, according to the American Cancer Society 2022, 1,898,160 new cancer cases and 608,570 cancer deaths were projected to occur in the United States in 2022. Moreover, as per the American Cancer Society, Cancer Facts & Figures 2022, a little over 1.9 million new cancer cases were expected to be diagnosed in the US in 2022.
Another factor responsible for the growth of the Computed Tomography Devices market is the utilization of CT in the United States which has increased rapidly over time. Among Medicare beneficiaries, the increase in utilization has always been higher for medical imaging than other physician-provided services. Medical imaging contributes to accurate disease diagnosis and improved treatment. Therefore, the rising adoption of Computed Tomography Devices in the country would result in the rising demand for treatments that make use of Computed Tomography Devices, which in turn would provide a conducive growth environment for the United States Computed Tomography Devices market as well as the North American region.
Furthermore, the increased emphasis on product development activities and the high interest of device manufacturers in accessing local markets further aid in the growth of the regional markets for Computed Tomography Devices. For instance, in October 2022, Siemens Healthineers announced the Food and Drug Administration (FDA) 510 (k) clearance of the Naeotom Alpha, the world's first photon-counting computer tomograph.
These kinds of product launches in the local markets may drive the product demand in the market. Therefore, the interplay of various factors such as the presence of a large patient population, encouraging reimbursement policies as well as new product launches in the region is expected to boost the North America Computed Tomography Devices market during the forecast period.
Computed Tomography Devices Market Key Players:
Some of the key market players operating in the Computed Tomography Devices market include General Electric Company, FUJIFILM Holdings Corporation, Siemens Healthcare GmbH, Koninklijke Philips N.V., Canon Medical Systems Corporation, NeuroLogica Corp. (Samsung Electronics), Shimadzu Corp., Thermo Fisher Scientific, Xoran Technologies LLC, Trivitron Healthcare, Neusoft Medical Systems Co., Ltd., Shenzhen Anke High-Tech Co. Ltd., Shenzhen Basda Medical Apparatus Co. Ltd., PerkinElmer Inc., ICRco, Inc., MARS Bioimaging Ltd., United Imaging Healthcare Co., Ltd., SternMed GmbH, MinFound Medical Systems Co., Ltd, MR Solutions and others.
Recent Developmental Activities in the Computed Tomography Devices Market:
On May 19, 2022, Royal Philips announced the launch of its newest solution for precision diagnosis with the global introduction of its spectral detector-based Spectral Computed Tomography (CT) 7500. This latest intelligent system delivers high-quality spectral images for every patient on every scan 100% of the time to help improve disease characterization and reduce rescans and follow-ups, all at the same dose levels as conventional scans.
On February 18, 2022, Hitachi announced the conclusion of the absorption-type company split agreement relating to diagnostic imaging-related business (CT, MRI, X-RAY) to Fujifilm. This acquisition expanded FUJIFILM'S business in Medical Systems.
On December 16, 2020, FUJIFILM announced a CT partnership with UroPartners and chose to standardize the Persona CT Computed Tomography (CT) system to accelerate its oncology treatment planning capabilities. Designed and built in the US, the Persona CT is an innovative CT system from Fujifilm in partnership with Analogic. The system offers advanced oncology simulation and general radiography imaging capabilities with a focus on the patient experience.
On August 2, 2020, Siemens Healthineers inked a USD 16.4 billion deal to buy Varian Medical Systems to become the global leader in cancer care solutions.
Key Takeaways from the Computed Tomography Devices Market Report Study
Market size analysis for current Computed Tomography Devices market size (2023), and market forecast for 5 years (2024-2030)
The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the Computed Tomography Devices market.
Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years
Key companies dominating the global Computed Tomography Devices market.
Various opportunities available for the other competitor in the Computed Tomography Devices market space.
What are the top performing segments in 2023? How these segments will perform in 2030.
Which is the top-performing regions and countries in the current Computed Tomography Devices market scenario?
Which are the regions and countries where companies should have concentrated on opportunities for Computed Tomography Devices market growth in the coming future?
Target Audience who can be benefited from this Computed Tomography Devices Market Report Study
Computed Tomography Devices products providers
Research organizations and consulting companies
Computed Tomography Devices-related organizations, associations, forums, and other alliances
Government and corporate offices
Start-up companies, venture capitalists, and private equity firms
Distributors and Traders dealing in Computed Tomography Devices
Various End-users who want to know more about the Computed Tomography Devices market and latest technological developments in the Computed Tomography Devices market.
Frequently Asked Questions for Computed Tomography Devices Market:
Computed Tomography (CT) exams help physicians diagnose a range of conditions by producing images of internal organs and structures of the body. A CT scanner is an x-ray machine that combines many x-ray images with the aid of a computer to generate cross-sectional views and, if needed, three-dimensional images of the internal organs and structures of the body.
Global Computed Tomography (CT) Devices Market was valued at USD 6.13 billion in 2023, growing at a CAGR of 6.36% during the forecast period from 2024 to 2030 to reach USD 8.87 billion by 2030.
The Computed Tomography Devices market is witnessing a positive market growth owing to the rising incidence of severe chronic diseases such as cardiovascular, oncology, and others, rapid technological developmental activities, growing awareness for early detection, increasing incidences of the aging population.
Some of the key market players operating in the Computed Tomography Devices market include General Electric Company, FUJIFILM Holdings Corporation, Siemens Healthcare GmbH, Koninklijke Philips N.V., Canon Medical Systems Corporation, NeuroLogica Corp. (Samsung Electronics), Shimadzu Corp., Thermo Fisher Scientific, Xoran Technologies LLC, Trivitron Healthcare, Neusoft Medical Systems Co., Ltd., Shenzhen Anke High-Tech Co. Ltd., Shenzhen Basda Medical Apparatus Co. Ltd., PerkinElmer Inc., ICRco, Inc., MARS Bioimaging Ltd., United Imaging Healthcare Co., Ltd., SternMed GmbH, MinFound Medical Systems Co., Ltd, MR Solutions, and others.
North America is expected to hold the highest share in the revenue in the Computed Tomography Devices market during the forecast period. Factors such as the rising incidence of cancer cases, increase in the utilization of CT, technical improvements, strong financial incentives, and increased product launches are expected to aid in the growth of the North America Computed Tomography Devices Market in this region.